...My name is Patrick Trucchio, and I am a Senior Biotech Analyst at H.C. Wainwright. It's my pleasure to introduce our next presenters, Vipin Garg, CEO; and Scott Harris, Chief Medical Officer of Altimmune, a clinical stage biopharmaceutical company focusing on developing treatments for obesity and liver disease. So I think maybe just to start, if we could talk about Altimmune's synthetic peptide technology platform, how did this come to be in its current form and what makes it differentiated from others in the market? Vipin Garg ...